Andrew Rubinstein
Founder at Oberland Capital Management LLC
Andrew Rubinstein active positions
Companies | Position | Start | End |
---|---|---|---|
Oberland Capital Management LLC
Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Founder | 2012-12-31 | - |
Private Equity Investor | 2012-12-31 | - | |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Director/Board Member | - | - |
Career history of Andrew Rubinstein
Former positions of Andrew Rubinstein
Companies | Position | Start | End |
---|---|---|---|
Microban International Ltd.
Microban International Ltd. Chemicals: Major DiversifiedProcess Industries Microban International Ltd. provides built-in antimicrobial product protection and antifungal solutions. The firm serves consumer, industrial and medical product to avoid the growth of microbes, such as bacteria, mold and mildew that can cause stains, odors and deterioration of a product. It has locations in North America, Latin America, Europe and Asia. The company was founded in 1984 and is headquartered in Huntersville, NC. | President | - | - |
Merrill Lynch & Co., Inc. | Corporate Officer/Principal | - | - |
Paul Capital Partners LP
Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Private Equity Investor | 2006-12-31 | - |
Training of Andrew Rubinstein
University of Pennsylvania | Graduate Degree |
New York University | Graduate Degree |
Statistics
International
United States | 8 |
Operational
Private Equity Investor | 2 |
Graduate Degree | 2 |
Undergraduate Degree | 1 |
Sectoral
Finance | 4 |
Consumer Services | 3 |
Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
Paul Capital Partners LP
Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Finance |
Microban International Ltd.
Microban International Ltd. Chemicals: Major DiversifiedProcess Industries Microban International Ltd. provides built-in antimicrobial product protection and antifungal solutions. The firm serves consumer, industrial and medical product to avoid the growth of microbes, such as bacteria, mold and mildew that can cause stains, odors and deterioration of a product. It has locations in North America, Latin America, Europe and Asia. The company was founded in 1984 and is headquartered in Huntersville, NC. | Process Industries |
Merrill Lynch & Co., Inc. | Finance |
Oberland Capital Management LLC
Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Finance |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Commercial Services |
- Stock Market
- Insiders
- Andrew Rubinstein
- Experience